➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Colorcon
Dow
Express Scripts
Moodys
Johnson and Johnson

Last Updated: October 18, 2021

DrugPatentWatch Database Preview

Generic Companies with Tentative Approvals for: ibrutinib


Email this page to a colleague

« Back to Dashboard

ibrutinib Generic Filers with Tentative Approvals

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

Applicant Generic Name NDA Strength Dosage Form
Zydus Worldwide Dmcc ibrutinib 214296 560MG TABLET;ORAL
Zydus Worldwide Dmcc ibrutinib 214296 280MG TABLET;ORAL
Teva Pharms Usa Inc ibrutinib 211350 140MG CAPSULE;ORAL
Alvogen Inc ibrutinib 214498 140MG CAPSULE;ORAL
Alvogen Pine Brook ibrutinib 212763 560MG TABLET;ORAL
>Applicant >Generic Name >NDA >Strength >Dosage Form

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Harvard Business School
Express Scripts
Merck
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.